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Human CD341 stem cells express the hiwi gene, a human homologue
of the Drosophila gene piwi
Arun K. Sharma, Mary C. Nelson, John E. Brandt, Maija Wessman, Nadim Mahmud, Kevin P. Weller, and Ronald Hoffman
Hematopoieticstemcells(HSCs)arechar-
acterized by their dual abilities to un-
dergodifferentiationintomultiplehemato-
poietic cell lineages or to undergo self-
renewal. The molecular basis of these
properties remains poorly understood.
Recently the piwi gene was found in the
embryonic germline stem cells (GSCs) of
Drosophila melanogaster and has been
shown to be important in GSC self-
renewal. This study demonstrated that
hiwi, a novel human homologue of piwi, is
also present in human CD341 hematopoi-
eticprogenitorcellsbutnotinmorediffer-
entiated cell populations. Placing CD341
cells into culture conditions that sup-
ported differentiation and rapid exit from
the stem cell compartment resulted in a
loss of hiwi expression by day 5 of a
14-day culture period. Expression of the
hiwi gene was detected in many develop-
ing fetal and adult tissues. By means of 5*
RACE cloning methodology, a novel puta-
tive full-length hiwi complementary DNA
was cloned from human CD341 marrow
cells. At the amino acid level, the human
HIWI protein was 52% homologous to the
Drosophila protein. The transient ex-
pression of hiwi in the human leukemia
cell line KG1 resulted in a dramatic
reduction in cellular proliferation. Over-
expression of hiwi led to programmed
cell death of KG1 cells as demonstrated
by the Annexin V assay system. These
studies suggest that hiwi maybe an
important negative developmental regu-
lator, which, in part, underlies the unique
biologic properties associated with he-
matopoietic stem and progenitor cells.
(Blood. 2001;97:426-434)
© 2001 by TheAmerican Society of Hematology
Introduction
Hematopoietic stem cells (HSCs) have the unique ability to
undergo self-renewal and to differentiate into cells belonging to
multiple hematopoietic lineages.1,2 These properties allow stem
cells to maintain hematopoiesis throughout the life span of an
organism.The knowledge of the behavior of HSCs is limited due to
their rarity, difﬁculty of efﬁcient isolation, and sensitivity to
manipulation.1,2 The self-renewal capacity of several classes of
stem cells is thought to be controlled by external signals and intrinsic
cellular processes.1-4 Over the last 2 decades, a variety of external
stimuli (cytokines, matrix proteins) that alter HSC self-renewal
have been the subject of intense investigation. Although a number
of such external signals that interact with speciﬁc receptors on HSC
have been identiﬁed, the signaling mechanisms that govern HSC
self-renewal have eluded investigation. Intrinsic cellular mecha-
nisms that regulate stem cell self-renewal have been explored in a
variety of model systems including germline stem cells (GSCs) in
several lower species. Drosophila has been a particularly useful model
forstudyingbiologicprocessesthatareconservedinhigherdevelopmen-
tal systems.5-12 Therefore, in an attempt to deﬁne candidate genes
that are responsible for human HSC self-renewal, we have explored
the expression of genes in humans that have recently been
demonstrated to play a role in Drosophila GSC self-renewal.
The GSCs provide a continuous source of totipotent cells for the
production of gametes needed for fertilization.8 They are similar to
HSCs in their ability to not only self-renew but also to remain
capable of generating large numbers of differentiated daughter
cells.8,9The intracellular mechanisms that serve as the determinants
of asymmetric-segregating cell fates of GSCs depend not only on
the basic cell cycle machinery but also on a family of recently
identiﬁed genes, some of which are evolutionarily conserved.7,9
A group of somatic cells in Drosophila, termed terminal ﬁlament
cells, which lie distal and immediately adjacent to the GSCs, have been
shown to regulate GSC division.8,10,11 Laser ablation of the terminal
ﬁlament increases the rate of oogenesis by 40%.12 Loss of function
mutations in a gene found in the terminal ﬁlament, termed piwi, leads to
a failure of stem cell maintenance7,10; piwi is expressed not only in the
terminal ﬁlament but also in the germline. Loss of piwi function in the
germline, however, is not known to affect GSC division. The protein
encoded by piwi is extraordinarily well conserved along the evolution-
ary tree, being found in both Caenorhabditis elegans and primates.7Our
laboratory has attempted to determine if such genes were present in
primitive hematopoietic cells and if they might play a role in HSC
development.We report here the presence of a human homologue of the
piwigene,termedhiwi,inavarietyofprimitivehematopoieticcells.The
hiwi gene represents a candidate gene that may play a role in
determining or regulating HSC development.
Materials and methods
Isolation of human and baboon CD341 cells
Adult human bone marrow (BM) samples (15-30 mL) were aspirated from
the posterior iliac crests of healthy donors after informed consent was
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sity of Illinois at Chicago Institutional Review Board. Heparinized marrow
aspirates were diluted with Dulbecco phosphate-buffered saline (DPBS)
Ca11- and Mg11-free (Biowhittaker, Walkersville, MD). Diluted marrow
was then underlaid with Ficoll-Paque (Pharmacia AB, Uppsala, Sweden),
and centrifuged at 800g for 30 minutes at 20°C. The mononuclear cell
fraction was collected and the CD341 cells were immunomagnetically
enriched using the MACS CD34 Isolation Kit (Miltenyi Biotec, Auburn,
CA). Brieﬂy, cells were incubated with hapten-labeled anti-CD34 antibody
(QBEND-10, Becton Dickinson) in the presence of blocking reagent,
human IgG (Bayer, Elkhart, IN), and then with antihapten coupled to
MACS microbeads. Labeled cells were ﬁltered through a 30 mm nylon
mesh and separated using a high-gradient magnetic separation column.
Magnetically retained cells were eluted and stained with monoclonal
antibodies (MoAb) and analyzed using ﬂow cytometric methods. The
ﬂow-through population was identiﬁed as CD342 cells. The purity of the
CD341 population was routinely more than 90% (data not shown).
The BM aspirates were obtained from the humeri and iliac crests of
juvenile baboons (Papio anubis) after ketamine (10 mg/kg) and xylazine (1
mg/kg) anesthesia according to the guidelines established and approved by
the University of Illinois at Chicago Animal Care Committee. Heparinized
marrow was diluted 1:15 in phosphate-buffered saline (PBS) and the
mononuclear cell fraction obtained by centrifugation over 60% Percoll
(Pharmacia AB) at 500g for 30 minutes at 20°C. The antihuman CD34
MoAb K6.1 (a gift from the Naval Medical Research Institute, Bethesda,
MD), a murine IgG2a, which cross-reacts with baboon CD34 antigen, was
used for the selection of the CD341 fraction of marrow cells.13 The
mononuclear cells were suspended in PBS containing 0.2% bovine serum
albumin (BSA; Sigma Chemical, St Louis, MO) and stained ﬁrst with
biotin-conjugated K6.1 (20 mg/mL), washed, and labeled with Miltenyi
streptavidin-conjugated iron microbeads (Miltenyi Biotec) and selected as
described above according to manufacturer’s instructions.
Flow cytometric analysis and sorting
Isolated human CD341 cells were further fractionated based on the
expression of CD38 antigen.14 Nonspeciﬁc staining was blocked using
0.1% heat-inactivated human gamma globulin (Bayer). Cells were stained
with anti-CD34 MoAb conjugated to ﬂuorescein isothiocyanate (FITC)
(Becton Dickinson) and anti–CD38-phycoerythrin (PE) (Becton Dickin-
son). Control cells were incubated with ﬂuorochrome-conjugated isotype-
matched IgG1-FITC (Becton Dickinson) and IgG1-PE (Becton Dickinson).
Immediately prior to sorting 1 mg/mL propidium iodide (PI) was added for
the identiﬁcation and exclusion of nonviable cells. Cells were sorted and
analyzed on a FACSVantage cell sorter (Becton Dickinson). FITC, PE, and
PI were excited at a wavelength of 488 nm using an argon ion laser. The
CD341 cells were sorted into CD382, CD38lo, and CD38hi subpopulations.
Positive ﬂuorescence for each of the markers was established as ﬂuores-
cence more than 99% of isotype-matched irrelevant murine IgG1 controls.
Cell aggregates or debris were excluded by forward and 90° light scatter.
All staining for analysis and sorting was done in the presence of 0.2% BSA
in PBS on ice.
Stroma-free expansion cultures
To promote differentiation of human CD341 cells, a stroma-free suspension
culture was established as previously described.15 Tissue culture dishes (35
mm; Corning, Corning, NY) were seeded with 1 3 106 CD341 cells/ well
in 3 mL Iscove modiﬁed Dulbecco medium (IMDM) (BioWhittaker)
containing 10% fetal bovine serum (FBS; Hyclone, Logan, UT). Cultures
were placed at 37°C in 100% humidiﬁed atmosphere of 5% CO2 in air. At
initiation of cultures and at 72- to 96-hour intervals, cultures received a
combination of recombinant cytokines: stem cell factor (SCF), interleukin
(IL)-3, and granulocyte colony-stimulating factor (G-CSF) all at 100 ng/mL
(R&D Systems, Minneapolis, MN). Cultures were maintained at a cell
concentration of 5 3 105 to 2 3 106 viable cells/mL.
Leukemia cell lines
The TF-1 lymphoblast cell line; Jurkat, a T-lymphocyte cell line; CEM, an
acute T lymphoblast cell line; BV-173, a B-cell precursor cell line; K-562, a
chronic myeloid cell line; KG1 and KG1a, acute myeloid cell lines; and
SUPB13, an acute B lymphoblastic cell line were obtained through the
American Type Culture Collection (ATCC; Rockville, MD; SUPB13, a gift
from Steve Smith at the University of Chicago, Chicago, IL). The lines
were maintained in RPMI 1640 (Biowhittaker) supplemented with 10%
heat-inactivated FBS (except for KG1 and KG1a, which required the
presence of 20% FBS), 2 mM L-glutamine, 100 U/mL penicillin, 1 mg/mL
streptomycin (Biowhittaker). Granulocyte/macrophage CSF (GM-CSF; 5
ng/mL; Peprotech, Rocky Hill, NJ) was added to TF-1 culture. Cell density
was maintained at 1 3 105 to 1 3 106 viable cells/mL.
Mesenchymal stem cells
Mesenchymal stem cells were isolated and expanded from normal human
BM aspirates as described by Pittenger and coworkers.16 These puriﬁed
cells were kindly provided by Osiris Therapeutics (Baltimore, MD).
Stromal cells
Bone marrow stroma was grown by seeding 1 3 106 low-density BM
cells/162 cm2 (Corning) ﬂask in low-glucose Dulbecco modiﬁed Eagle
medium (DMEM; Mediatech, Herndon, VA) supplemented with 10%
heat-inactivated FBS and 2 mM L-glutamine, 100 U/mL penicillin, 1
mg/mL streptomycin.17,18 Adherent cells were split at conﬂuency and the
nonadherent cells were discarded.Adherent cells were passaged 4 times and
were then termed marrow stroma.17,18
RNA isolation
Total RNA was isolated from hematopoietic, stromal, and mesenchymal
cells using Trizol (Life Technologies, Gaithersburg, MD) according to the
manufacturer’s instructions. Cells were pelleted and then resuspended in 1
mL Trizol per 5 3 106 cells by repeated pipetting. The cell lysate was then
incubated for 5 minutes at room temperature and extracted with 0.2
volumes chloroform by vortexing for 1 minute. The sample was then
centrifuged for 30 minutes at 13 000 rpm (12 000g), 4°C in a microcentri-
fuge. The RNA was precipitated using 2 volumes isopropanol, mixed and
allowed to sit at room temperature for 10 minutes. The RNA was
centrifuged for 45 minutes at 13 000 rpm (12 000 g). The RNAwas washed
with 75% ethanol, brieﬂy dried, and resuspended in RNase-free water or
diethyl pyrocarbonate–treated (DEPC; Sigma Chemical) water (0.1%).
RNA was then quantitated using a DU 650 spectrophotometer (Beckman
Instruments, Palo Alto, CA). RNA was DNase treated using DNase I
enzyme (Life Technologies) according to the manufacturer’s instructions.
Cloning of hiwi complementary DNA from human testis
Polymerase chain reaction (PCR) ampliﬁcation was performed on RNA
samples using either a RNAPCR Core Kit (PerkinElmer, Foster City, CA),
according to the manufacturer’s instruction, except that High Fidelity
Platinum Taq DNA Polymerase (Life Technologies) was substituted for
AmpliTaq or a Stratagene ProSTAR First-Strand RT-PCR Kit (Stratagene,
La Jolla, CA). One microgram of total RNA was used for complementary
DNA (cDNA) synthesis using random hexamers to prime ﬁrst-strand
synthesis. The synthesized CD341 cell cDNA was divided and used for
PCR ampliﬁcation. As a control, duplicate cDNA synthesis reactions were
performed for each experiment without the addition of reverse transcrip-
tase. Control PCR ampliﬁcation reactions were performed using primers for
glyceraldehyde phosphate dehydrogenase cDNA (GAPD; forward, 59-
ggctgagaacgggaagcttgtcat-39; reverse, 59-cagccttctccatggtggtgaaga-39) for
1 cycle at 94°C/2 minutes; 5 cycles at 94°C/10 seconds, 70°C/2 minutes; 5
cycles at 94°C/10 seconds, 68°C/2 minutes; 25 cycles at 94°C/10 seconds,
66°C/2 minutes, and 1 cycle at 72°C/10 minutes, which produced a
142-base pair (bp) product. b2-Microglobulin primers were also used as an
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verse,59-catgtctcgatcccacttaac-39)producinga329-bpproduct.PCRampli-
ﬁcation primers were designed based on the partial published hiwi DNA
sequence found in the Genbank database (accession number AF104260).
Detection of hiwi in CD341 DNase treated RNA was performed using the
primer pair hiwiF269 59-gaagcagcctgtcttggtcagc-39 and hiwiR269 59-
gaatcaaagctcaaaccccagtctc-39 producing a 269-bp product. Two primer
pairs were initially designed to be used in 59 RapidAmpliﬁcation of cDNA
Ends (59 RACE) PCR strategy cloning19 AKSrev1 (reverse primer #1;
59-cgctgtatgtggtctggcttcaggc-39) and AKSrev2 (reverse primer #2; 59-
gggagaaacactaccacttctcacagcctg-39). AKSrev2 is 32 nucleotides upstream
from AKSrev1 and serves as a nested internal control for secondary PCR
ampliﬁcation. Marathon Ready Human Testis cDNAKit (Clontech Labora-
tories, Palo Alto, CA) was used for primary ampliﬁcation, according to
manufacturer’s instructions. First round PCR ampliﬁcation consisted of
AKSrev1 and AP-1 (59-ccatcctaatacgactcactatagggc-39), supplied within
the cDNAKit, under the following conditions: 1 cycle at 94°C/2 minutes; 5
cycles at 94°C/10 seconds, 71°C/2 minutes; 5 cycles at 94°C/10 seconds,
69°C/2 minutes; 25 cycles at 94°C/10 seconds, 67°C/2 minutes, and 1 cycle
at 72°C /10 minutes. A single PCR product was separated on a 1%
SeaPlaque Agarose (FMC, Rockland, ME) 1 3 TAE gel stained with
ethidium bromide and puriﬁed from the agarose using a Wizard PCR Prep
Kit (Promega, Madison,WI).The isolated PCR fragment was then used in a
second round of PCR ampliﬁcation that used the same PCR ampliﬁcation
conditions listed above except that AKSrev2 was substituted for AKSrev1
and AP-2 (59-actcactatagggctcgagcggc-39) replaced AP-1. All PCR reac-
tions were performed in a PerkinElmerThermal Cycler 9700 (PerkinElmer)
or Stratagene Robocycler Gradient 96 Thermal Cycler.
Cloning of hiwi cDNA from human CD341 cells
Human CD341 cells were puriﬁed and total RNA isolated as previously
described. Based on a sequence obtained from the human testis clone,
primers were designed to amplify a putative full-length cDNA clone,
FLhiwifor1 (forward, 59-atgatctttggtgtgaacacaaggcagaa-39) and FLhi-
wirev1 (reverse 59-gaggtagtaaaggcggtttgacagtgacaga-39). PCR ampliﬁca-
tion conditions were as follows: 1 cycle at 94°C/2 minutes; 5 cycles at
94°C/10 seconds, 72°C/2 minutes; 5 cycles at 94°C/10 seconds, 70°C/2
minutes; 25 cycles at 94°C/10 seconds, 68°C/2 minutes, and 1 cycle at
72°C/10 minutes.
DNA sequencing
Direct DNA sequencing of the PCR product was performed using an ABI
Prism Dye Terminator Cycle Sequencing Reaction Kit (PerkinElmer)
according to the manufacturer’s instructions.Additional primers (Integrated
DNA Technologies, Coralville, IA) were synthesized based on analyzed
sequence to obtain the complete cDNAsequence.
Tissue distribution analysis
The PCR ampliﬁcation was performed on 3 different multiple tissue cDNA
panels: human I, human II, and human fetal (Clontech Laboratories). The
following PCR conditions were used for ampliﬁcation with primer pair
GSP2F4(forward,59-ccttgccagtacgcccacaagctg-39)andGSP1R1966(reverse,
59-ccccacctatggttgtagtgagcatcc-39): 1 cycle at 94°C/2 minutes; 35 cycles at
94°C/10 seconds, 70°C/15 seconds, 72°C/45 seconds; and 1 cycle at
72°C/10 minutes, which produced a 557-bp product. Positive samples were
separated on a 1% SeaPlaque Agarose (FMC) 1 3 TAE gel stained with
ethidium bromide and puriﬁed from the agarose using theWizard PCR Prep
Kit according to the manufacturer’s instructions. Asymmetric restriction
endonuclease digestion was performed to determine the identity of the PCR
products (data not shown).
Subcloning of hiwi into expression vector
After obtaining the putative full-length hiwi cDNA, the fragment was then
subcloned into the XhoI/NotI sites of the pCIneo Mammalian Expression
Vector (Promega) and used for expression studies.
Transfection and G418 selection of transfected KG1 cells
Transfection of KG1 cells was accomplished using electroporation. Electro-
poration of plasmid DNA into KG1 cells was performed using a Bio-Rad
Gene Pulser II System (Bio-rad Laboratories, Hercules, CA). Fifty micro-
grams of pCIneo or pCIneo-hiwi was electroporated per 1 3 105 KG1 cells
accompanied with 2 mg linearized vector for each respective condition as
well as a mock control that consisted of KG1 cells alone. All cells were
washed with and then resuspended in DPBS prior to electroporation. The
electroporation conditions were as follows: 300 V, 950 mF, using a 0.4-cm
gapped cuvette (Bio-rad Laboratories) for each condition. Cells were then
centrifuged and washed twice with DPBS and resuspended in IMDM
supplemented with 20% heat inactivated FBS, 100 U/mL penicillin, 1
mg/mL streptomycin, and 2 mM L-glutamine and incubated overnight at
37°C in a 100% humidiﬁed incubator containing 5% CO2 in air. Cells were
then counted and stained for viability using a 0.4% trypan blue solution
(Sigma) on the following day. Cells were then plated at a density of 2 3 104
viable cells per well in a ﬂat-bottom 96-well plate (Corning) in IMDM
supplemented with 5% heat inactivated FBS, 100 U/mL penicillin, 1
mg/mL streptomycin, and 2 mM L-glutamine. Cells exposed to each
experimental condition were plated in 6 separate cultures for 7 days.
Several sets of transfected cells were plated under similar conditions for
detection of the hiwi gene by PCR and for antibiotic selection. Similar
populations of cells (pCIneo vector alone, the pCIneo-hiwi, or cells alone)
were then incubated in IMDM supplemented with 20% FBS, 100 U/mL
penicillin, 1 mg/mL streptomycin, and 2 mM L-glutamine containing 1
mg/mL Geneticin Selective Antibiotic (G418 sulfate; Life Technologies)
for 3 weeks.
Cell proliferation assay
Cell proliferation and survival were measured by cellular uptake of MTT
(3,-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide; Sigma-
Aldrich), which measures living cells.15 Fifty microliters of a 1 mg/mL
solution of ﬁlter sterilized MTT in DPBS was added to each culture volume
of 200 mLcontaining 2 3 104 viable cells per well and then incubated for 4
hours at 37°C in a 100% humidiﬁed incubator, 5% CO2 in air. Approxi-
mately half of the volume was then carefully removed (without disrupting
the solubilized complex) and replaced with developing reagent that
consisted of 40 mM hydrochloric acid in isopropanol. After thoroughly
homogenizing the solubilized complex with the developing reagent, the
plate was then read on a ELX-800 ELISAplate reader (Bio-tek Instruments,
Winooski,VT) at wavelength of 570 nm with a reference wavelength of 630
nm as previously described.15 This procedure was performed on days 1 to 6
and then on day 9.
PCR detection of hiwi in transfected KG1 cells
The KG1 cells (5 3 105) that were transfected with either the pCIneo vector
alone, the pCIneo-hiwi, or cells alone were then harvested. Total RNA was
isolated and cDNA was synthesized as previously described. PCR ampliﬁ-
cation conditions were similar to those described previously.
Apoptosis assay
The KG1 cells were transfected under the 3 separate conditions as
previously described. Condition 1 consisted of a mock transfection,
condition 2 consisted of an empty vector control transfection, and condition
3 consisted of the vector containing hiwi.An additional sample of KG1 cells
was also serum-starved for 24 hours in IMDM, 2 mM L-glutamine, 100
U/mL penicillin, and 1 mg/mL streptomycin (Biowhittaker). Incubation
conditions are similar to those described above. Transfected cells were
maintained in culture for up to 32 hours and then assayed for programmed
cell death by the Annexin V assay system (Pharmingen, San Diego, CA)
according to the manufacturer’s instructions. Brieﬂy, cells were washed
with DPBS, collected, and then resuspended in binding buffer containing
Annexin V–FITC and PI at room temperature. Acquisition and analysis of
data were performed on a FACSCalibur (Becton Dickinson) using the
CellQuestAnalysis Software (Becton Dickinson).
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by computer-based mapping
The hiwi chromosome localization was achieved by comparing expressed
sequence tags (EST) and the sequence tagged site (STS) to the partial
published sequence of hiwi and verifying position through computer-based
radiation hybrid homology searches.20,21
Fluorescence in situ hybridization (FISH)
Metaphase spreads were prepared from phytohemagglutinin (PHA)-
stimulated peripheral blood lymphocytes of a healthy human male,
according to standard protocols. Cells were treated with 5-bromodeoxyuri-
dine (BrdU) at an early replicating phase to induce banding pattern.22 Slides
were stained with Hoechst 33258 (1 mg/mL) for 10 minutes and exposed to
UV light (302 nm) for 30 minutes. Before hybridization, metaphase slides
were pretreated with RNase (100 mg/mL) and pepsin (20 mg/mL) to avoid
nonspeciﬁc hybridization. An approximate 80 kilobase (kb) genomic DNA
fragment was cloned into the pBELObac 11 vector after screening a human
BAC library (Human Genome Systems, St. Louis. MO) with the original
hiwi cDNA clone and was labeled with biotin 11-dUTP (Sigma Chemical)
by nick translation according to standard protocols. The FISH procedure
was carried out in 50% formamide and 10% dextran sulfate in 2 3 standard
sodium citrate (SSC) as described earlier.23,24 Repetitive sequences were
suppressed with a 10-fold excess of human Cot-1 DNA(LifeTechnologies).
After overnight incubation, nonspeciﬁc hybridization and background
signals were eliminated by washing the slides 3 times with 50% formamide/
2 3 SSC and 3 times with 2 3 SSC at 42°C. Speciﬁc hybridization signals
were visualized using FITC-conjugated avidin (Vector Laboratories) and
counterstained with DAPI (49-69-diamino-2-phenylindole; Sigma; 0.025
mg/mL).25Amulticolor image analysis system was used for acquisition and
display of hybridization signals of metaphase chromosomes. The system
consists of a Zeiss Axioplan Imaging ﬂuorescence microscope (Zeiss,
Stuttgart, Germany) attached to a PC workstation.
Results
hiwi is expressed in CD341 hematopoietic cells
but not in CD342 cells
Semiquantitative reverse transcriptase PCR (RT-PCR) was per-
formed using RNA isolated from immunomagnetically separated
CD341 and CD342 cells from nonhuman primates (Papio anubis),
and from humans. A 269-bp band correlating to the same size as
seen in the human testis positive control was viewed in the CD341
population and not in the CD342 population of both human and
baboon. Sequence analysis conﬁrmed that the PCR product ob-
tained was the hiwi cDNA (Figure 1). To examine if hiwi
expression was restricted to the most primitive subpopulation of
human CD341 cells, CD341 cells were sorted according to CD38
expression into 3 subpopulations: CD341CD382 , CD341CD38lo,
CD341CD38hi (Figure 2A). Semiquantitative RT-PCR on DNase-
treated RNAisolated from each population showed that each of the
3 subpopulations expressed hiwi. These data indicate the hiwi
expression is not limited to the most primitive progenitor cell
population (Figure 2B).
Expression of hiwi diminishes as CD341 cells differentiate
The CD341 cell differentiation was promoted in a suspension
culture system to which SCF, IL-3, and G-CSF were added each at
100 ng/mL every 3 to 4 days. Bazil and colleagues15 have
previously shown these conditions allow for rapid proliferation and
differentiation causing the cells to leave the CD341 compartment.
Aliquots of cells were harvested on days 0, 1, 3, 5, 7, 10, and 14 and
analyzedbyﬂowcytometryforCD341expressionandbysemiquan-
titative RT-PCR for the hiwi messenger RNA(mRNA) (Figure 3A).
On day 0, the starting cell population was composed of 99%
CD341 cells. Day 5 CD341 content diminished to 20% of the
expanded cell population; by day 7, fewer than 0.1% of the cells
were CD341, and by day 10 there were no detectable CD341 cells
present. By day 3, hiwi expression was markedly reduced and no
longer detectable by semiquantitative RT-PCR by day 5. Concur-
rently b2-microglobulin gene expression was used as an internal
Figure 1. hiwi is expressed in human CD341 cells but not in CD342 hematopoi-
etic cells. Electrophoretic gel shows positive signal for hiwi in CD341 sample and no
signal in CD342 sample by semiquantitative RT-PCR. Lane 1, 123-bp DNA ladder;
lane 2, CD341 sample; lane 3, CD342 sample; lane 4, negative control (water) PCR
reactions; lane 5, positive control (human testis, 269 bp).
Figure 3. Loss of hiwi expression during differentiation of CD341 marrow cells.
CD341 cells were placed in suspension culture with G-CSF, IL-3, and SCF at 100
ng/mL added every 3 to 4 days. (A) Expression of hiwi as detected by semiquantita-
tive RT-PCR. Lane 1, 123-bp DNA ladder; lane 2, day 0 CD341 cells; lane 3, day 0
CD34
2 cells; lane 4, day 1 culture sample; lane 5, day 3 culture sample; lane 6, day 5
culture sample; lane 7, day 7 culture sample; lane 8, day 10 culture sample; lane 9,
day 14 culture sample; lane 10, negative control (water); lane 11, positive control
(human testis, 269 bp). (B) Internal control of b2-microglobulin gene expression
throughout 14 days of culture (330 bp). Lane numberings correspond to the same
samples as in panelA.
Figure 2. Expression of hiwi in subpopulations of CD341 cells. Immunomagneti-
cally selected CD341 human adult BM cells were sorted based on the CD38
expression. (A) Gates were established for the ﬂow cytometric isolation of CD341CD38hi,
CD341CD38lo, and CD341CD38neg. (B) Semiquantitative RT-PCR of hiwi in CD341
subpopulations. Lane 1, 123-bp DNA ladder; lane 2, CD341CD38neg sample; lane 3,
CD341CD38neg (2RT) sample; lane 4, CD341CD38lo sample; lane 5, CD341CD38lo
(2RT) sample; lane 6, CD341CD38hi sample; lane 7, CD341CD38hi (2RT) sample;
lane 8, negative control (water); lane 9, positive control (human testis, 269 bp).
CD341 STEM CELLS EXPRESS hiwi GENE 429 BLOOD, 15 JANUARY 2001z VOLUME 97, NUMBER 2
For personal use only. on November 7, 2014.  by guest    www.bloodjournal.org From control.The levels of b2-microglobulin remained constant through-
out the 14 days of culture (Figure 3B).
Expression of hiwi in leukemia cell lines
To examine whether the hiwi gene was expressed in leukemia cells,
we analyzed a variety of immortalized human leukemia cell lines
belonging to various lineages (Figure 4). Analysis of 8 immortal-
ized leukemia cell lines showed that the hiwi mRNAtranscript was
not detectable by RT-PCR.
Expression analysis of hiwi
To determine the expression pattern of hiwi in various adult and
fetal tissues other than CD341 marrow cells, PCR ampliﬁcation
was performed using hiwi-speciﬁc primers on cDNA samples
(Clontech Laboratories). Fetal cDNAsamples ranged from 18 to 36
weeks of gestation. The expression level was determined through
semiquantitative PCR ampliﬁcation and revealed a wide distribu-
tion of hiwi through most fetal and adult tissues (Figure 5). The
highest level of expression in fetal tissues was found in the kidney.
Analysis of adult samples showed that hiwi was also expressed in a
wide range of tissues such as the prostate, ovary, small intestine,
heart, brain, liver, skeletal muscle, kidney, and pancreas. The
highest level of expression was seen in the testis followed by the
kidney. Expression of hiwi was not detected in mesenchymal stem
cells or marrow stroma.
Cloning of hiwi from human marrow CD341 cells
The presence of hiwi in CD341 hematopoietic cells was deter-
mined through PCR ampliﬁcation by designing a primer pair that
spanned from amino acid 364 to 524 of the published partial coding
sequence generating a 480-bp fragment that corresponds to the
C-terminal end of the protein.After positively identifying the PCR
product to be that of hiwi through dye terminator cycle sequencing,
primers were then designed to amplify the potential full-length
gene from human testis cDNA by using a 59RACE cloning
methodology that allows the PCR ampliﬁcation of a given gene of
interest by using a small region of a known sequence.AKSrev1 and
AKSrev2 were also based on the published partial hiwi coding
sequence and acted as a nested primer pair for primary and
secondary PCR ampliﬁcation reactions and correspond to base
pairs 1391 to 1415 and 1330 to 1359, respectively. After using the
59 RACE methodology on the human testis cDNA sequence and 2
rounds of PCR ampliﬁcation (the second round consisting of a
nested PCR ampliﬁcation), a putative 2.3-kb full-length coding
sequence was cloned. After several rounds of sequencing through
primer walking, an open reading frame was determined. When
compared to the Genbank database of nonredundant clones, the
Figure 4. Expression of hiwi in human leukemia cell lines. (A) Lane 1, 1-kb
ladder; lane 2, TF-1; lane 3, Jurkat; lane 4, KG1a; lane 5, KG1; lane 6, K562; lane 7,
CEM; lane 8, BV173; lane 9,SUPB13; lane 10, negative control (water); lane 11,
human testis positive control (2.3 kb). (B) Samples without reverse transcriptase;
same setup as panel A, excluding lanes 7 through 11 (samples 7-9 were donated
cDNAs and total RNA samples were not available to perform the 2RT control). (C)
GAPD internal control (142 bp); lane numberings correspond to the same samples as
in panelA, excluding lanes 10 and 11.
Figure 5. Tissue distribution of hiwi mRNA. (A) Human fetal tissues. (B) Human
adult tissues (557 bp for both panels).
Figure 6. HIWI protein alignment. Amino acid alignment of the HIWI protein
(Genbank accession number AF264004) to the D. melanogaster PIWI protein
(Genbank accession number AF104355). Amino acid identities are indicated by
identical amino acid matches, whereas mismatches are indicated by a blank space.
The 1 signs refer to positions in which the nature of the residue is conserved as
reported by BLASTP homology alignment. Numbering begins at the initiation codon
of the PIWI sequence.
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PIWI protein at the amino acid level (Figure 6). Primer pairs were
then designed to amplify the full-length coding sequence from
CD341 hematopoietic cell cDNA through PCR ampliﬁcation. A
2.3-kb band was detected in the CD341 cDNA sample but not in
the no-template control. No bands were detectable in the absence of
reverse transcriptase (2RT) during the cDNA synthesis step.
Control PCR ampliﬁcation with primers to GAPD conﬁrmed that
the quantity and integrity of the RNAcould be PCR ampliﬁed. The
PCR product was sequenced and the identity was conﬁrmed to be
that of the hiwi gene by comparing it to the Genbank database.
Overexpression of hiwi leads to a diminished proliferative
capacity of KG1 cells as measured by MTT
The KG1 cells were chosen for these studies due to their lack of
expression of the hiwi mRNAas demonstrated by RT-PCR (Figure
4). Figure 7 shows that the proliferative capacity of the mock and
pCIneo vector-treated cells was similar, whereas treatment with the
pCIneo-hiwi construct led to a greatly diminished proliferation of
KG1 cells. To determine whether or not the hiwi gene was actually
expressed in the transfected cells, PCR was performed. Figure 8
shows the presence of the hiwi transcript from day 1 (24 hours after
transfection) until cultures were terminated (day 9). The declining
levels of the expressed gene were likely due to the fact that the cells
were not subjected to G418 antibiotic selection. To further assess
the function and integrity of each construct, populations of cells
that were simultaneously transfected were placed in the presence of
1 mg/mL active G418 for 3 weeks. After this period, the pCIneo-
hiwi construct and the pCIneo empty vector contained similar
numbers of viable cells. The pCIneo-hiwi construct further contin-
ued to express the hiwi gene (as determined by PCR, data not
shown). The mock transfected cells were, however, characterized
by a high degree of cell death at day 6 (. 96%, data not shown).
These studies demonstrate that both the cytomegalovirus (CMV)
promoter and the SV40 promoter (which was driving neomycin
phosphotransferase gene) were actively driving transcription of
their respective genes and that hiwi gene expression was present,
but to an unknown level. This study indicates that hiwi inhibits
KG1 cell proliferation and therefore suggests that this gene may
play a role in the negative regulation of hematopoietic cells.
Apoptosis of KG1 cells induced by hiwi
To determine a potential mechanism for the reduced proliferative
capacity of KG1 cells that overexpress the hiwi gene product,
apoptosis of these cells was evaluated using Annexin V as an
indicator of programmed cell death and PI as a measure of cell
viability. Figure 9D-F shows such an analysis after an 8 hours of
incubation demonstrating an approximate 4.4-fold increase (9.6%)
in the percentage of cells undergoing apoptosis, (positive for
Annexin V but negative for PI) when compared to the mock (1.8%)
and the empty vector control (2.4%). The degree of apoptosis after
12 hours of incubation is also greater in the hiwi overexpressing
cells as compared to the control cells. Flow cytometric analysis at
32 hours of culture (Figure 9J-L) exhibited an increase in the
number of cells that were PI and annnexin positive, suggesting that
the cells had proceeded to a necrotic state. These data indicate that
most of the cell population containing the hiwi gene underwent
apoptosis and eventually entered a terminal state of cell death.
Figure 7. MTT assay of KG1 cells with or without hiwi. KG1 cells were subjected
totransfectionunder3differentconditions(controlKG1,KG11pCIneo,KG11pCIneo-
hiwi) and were cultured for a 9-day period.An MTTassay was performed on each day
to assess cell proliferation from days 1 through 6 and then on day 9.
Figure 8. PCR detection of hiwi DNA in transfected KG1 cells. (A) PCR
ampliﬁcation of hiwi on mock transfected KG1 cells (d1-6, d9; lanes 2-8), empty
vector transfected KG1 cells(d1-6, d9; lanes 9-15), and hiwi-containing vector-
transfected KG1 cells (d1-6, d9; lanes 16-22). Lane 1 is a 1-kb DNA ladder. (B)
Samples without reverse transcriptase; same setup as panel A. (C) GAPD internal
control (142 bp), same setup as panelA.
Figure 9. Induction of apoptosis in KG1 cells overexpressing the hiwi gene.
KG1 cells were transfected under mock, pCIneo empty vector, or pCIneo-hiwi
conditions. Cells were harvested at 2, 8, 12, and 32 hours, washed with PBS, and
resuspended in binding buffer containing Annexin V–FITC and PI. The X-axis
represents log ﬂuorescence intensity forAnnexin V staining; theY-axis represents log
ﬂuorescence intensity for PI staining. Panels A-C show ﬂow cytometric analysis at a
2-hour time point that consists of a mock, a pCIneo empty vector, and the pCIneo-hiwi
transfected KG1 cell populations. Panels D-F, G-I, and J-L show the same analysis
but at 8,12, and 32 hours (respectively) after transfection.
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The chromosomal location of hiwi was determined by STS
computer-based mapping.20,21 Four different STS clones (Genbank
accession numbers AA639672, AA904973, AA969660, and
AI25224) were found to have signiﬁcant homology to the hiwi
gene.These 4 clones along with the partial published hiwi sequence
were then mapped to the reference interval of D12S340-D12S97
(147.5-160.9 cM) by radiation hybridization (Unigene cross-
reference Hs. 128673). The physical position of hiwi was located at
489.71 cR3000 (P1.43, stSG53541) on the q arm of chromosome
12, speciﬁcally between 12q24.2 through 12q24.32 as represented
by the cytogenetic ideogram. The physical locale of hiwi does not
currently show an association with any hematologic disorders (as
demonstrated by STS/EST homology comparisons).
Chromosomal localization of the human hiwi gene
by FISH analysis
To directly determine the chromosomal location of hiwi,ahiwi
genomic clone was hybridized on metaphase chromosomes derived
from a human peripheral blood cell culture. Identiﬁcation of the
human chromosomes was based on their DAPI-banding pattern
that resembles G-bands achieved by conventional trypsin-Giemsa
treatment. Thirty-two metaphase spreads were analyzed showing
speciﬁc localization to chromosome 12 as follows: speciﬁc hybrid-
ization signals were seen 9 times (28.1%) in 2 chromatids, 10 times
(31.3%) in 3 chromatids, and 11 times (34.4%) in 4 chromatids; no
hybridization signals were seen in 2 metaphases (6.2%). A very
small number of nonspeciﬁc hybridization sites were seen (Figure
10). Traditional FISH analysis conﬁrmed the computer-based
chromosomal localization of hiwi.
Discussion
Astem cell can undergo self-renewal as well as generate differenti-
ated progeny. The capacity of an HSC to remain undifferentiated
and be capable of reconstituting a myeloablated host as well as its
ability to generate multiple differentiated cell types is central to its
pivotal role in normal hematopoiesis. Despite the improved ability
of various laboratories to isolate and manipulate pure populations
of murine and human HSCs,26,27 our understanding of mechanisms
by which a stem cell divides and retains its unique biologic
properties has eluded the efforts of a large number of investiga-
tors.28-33 Understanding the basis of these properties is required if
progress in stem cell transplantation and gene therapy are to occur.
Stem cell division is likely controlled by both intracellular mecha-
nisms as well as cell to cell interactions. The intracellular mecha-
nisms of a stem cell would include basic cell cycle machinery as
well as machinery responsible for cell division.
Elucidation of the genetic program that underlies the unique
biologic properties of HSCs has been the focus of a growing
number of laboratory groups.33,34 These laboratories have at-
tempted to approach this daunting objective by using a variety of
approaches. Array technology, for instance, now permits one to
monitor simultaneously the expression patterns of thousands of
genes during cellular differentiation and response.35,36 The key to
the successful implementation of such technology to the study of
stem cell biology is the development of the means to assign priority
to such genes and to determine their function.
Recently our laboratory and several others have taken a
different approach to analyze the genetic organization of human
HSCs.37-39 Genes that were originally shown to affect stem cell
development in lower species have been shown subsequently to be
expressed by human hematopoietic cells and to have profound
regulatory effect on human hematopoieis. Lower organisms such as
Drosophila, C. elegans and Danio rerio (zebra ﬁsh) have been used
as effective models for studying mechanisms that are conserved
among diverse developmental systems.5,39,40 Studies from Xeno-
pus, for instance, have revealed a multitude of genes involved in
mesoderminductionincludingmembersofthetransforminggrowth
factor b superfamily, ﬁbroblast growth factor, and at least 19
members of the Wnt gene family in diverse species ranging from
roundworm and insects to humans.41,42 The Wnt gene family
members have subsequently been shown to have profound effects
on murine and human hematopoiesis.With this experience in mind,
we attempted to extend this approach to identify genes of interest
that might serve as candidate regulators of HSC self-renewal and
development.
In Drosophila, stem cells exist in the germline at the apical tip
of each ovariole, the germarium, which is the functional portion of
the ovary.12,43 Each ovary consists of 10 to 17 ovarioles. Each
germarium contains 2 to 3 GSCs that are in direct contact with
specialized somatic cells, the basal terminal ﬁlament cells.8,11,43
GSCs undergo asymmetric divisions to produce daughter stem
cells and a differentiated daughter cell, a cystoblast. Recently a
number of genes including dpp, piwi, pumilio, and fs1Yb have been
identiﬁed and shown to be essential for GSC maintenance.7,10,44
Among these genes, piwi has been of special interest. It has
recently has been demonstrated to be an essential stem cell gene in
Drosophila and C. elegans and to be expressed in tissues belonging
to many species including human. The Drosophila piwi gene is
required for asymmetric division of GSCs but is not required for
differentiation of committed daughter cells. Expression of piwi in
adjacent somatic cells, terminal ﬁlament cells, regulates GSC
division.7 We have therefore, embarked on studies of piwi homo-
logue gene expression during human hematopoiesis with the hope
of determining if this gene might regulate human HSC function.
Our laboratory has demonstrated that the human equivalent of
piwi, termed hiwi, is expressed in a variety of human tissues
including primitive hematopoietic cells. The gene was cloned from
human marrow CD341 cells and the HIWI protein was shown to
have 52% homology with the Drosophila PIWI protein at the
Figure 10. Chromosomal localization by FISH analysis. Chromosomal localiza-
tion of hiwi using a hiwi genomic clone shows hybridization of the genomic probe to
the q arm of chromosome 12, speciﬁcally between 12q24.2 through 12q24.32.
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By using 2 different approaches, we have shown that hiwi
expression within the hematopoietic compartment is unique to the
most primitive hematopoietic progenitors and is diminished or
absent in more differentiated cells. CD341 marrow cells contain
hematopoietic stem and early progenitor cells, which express hiwi,
in contrast to CD342 cells, which are predominantly composed of
more differentiated precursor cells. Although studies in the mouse
have recently demonstrated the presence of quiescent stem cells
within the CD342 subpopulation, the presence of such a CD342
stem cell in humans remains uncertain.27,45 Nevertheless, this
CD34
2 stem cell population would potentially represent an ex-
tremely small fraction of the total HSC population. Furthermore,
when CD341 cells were placed in conditions that favored differen-
tiation in vitro, hiwi gene expression declined synchronously with
cellular differentiation. Both groups of studies indicate that hiwi
expression is unique to the more primitive cellular compartment
and that its expression might serve as a genetic marker of
progenitor and stem cells.
Because leukemia is frequently accompanied by expansion of
the hematopoietic compartment, we anticipated that leukemia cells
would express hiwi, a gene that is associated with self-replication.
To our surprise, when 8 immortalized leukemia cell lines were
analyzed, hiwi mRNAtranscripts were undetectable. These studies
suggest that hiwi expression may not be a component of the genetic
program that accompanies leukemogenesis. By contrast, hiwi
expression appears to be limited within the hematopoietic compart-
ment to normal CD341 cells. These data indicate that the lack of
hiwi expression may be a consequence of the leukemic transforma-
tion event. Further testing of this potentially important ﬁnding will
be pursued with primary leukemia cells.
To determine if hiwi plays a regulatory role in human hemato-
poiesis, we attempted to overexpress the hiwi gene in an immortal-
ized acute myeloid leukemia cell line, KG1. The biologic activity
of hiwi was assessed using a standard cell proliferation assay
(MTT), which demonstrated that overexpression of the hiwi gene
product actually caused a decrease in cell proliferation when
compared with 2 separate controls. The magnitude of hiwi activity
was evaluated by direct comparison of cells exposed to the empty
vector control and the mock transfection control. Under both of
these conditions, KG1 cells were capable of proliferating normally
without the presence of the hiwi gene or interference from the
empty vector control. Comparing the optical density of both
controls with the hiwi-expressing culture shows a dramatic func-
tional decline in the metabolic machinery of the cells in this culture
condition. The overexpression of the hiwi gene product promoted
apoptosis in KG1 cells. The rapid progression of apoptosis can be
seen at the 8-hour time point where a majority of the cells in the
hiwi-containing population have undergone apoptosis and have
started to proceed into the necrotic state. These studies suggest that
hiwi overexpression causes programmed cell death. Lack of
apoptosis in the cells transfected with the hiwi gene, which were
maintained in selective media, may be due to the SV40 promoter
(which drives the transcription of the neomycin phosphotransferase
gene),outcompetingtheCMVpromoter(whichdirectsthetranscrip-
tion of the hiwi gene) because of the selective pressure placed on
the SV40 promoter by the G418 selection. This may account for
diminished expression of the hiwi gene product while the transcrip-
tion of the neomycin phosphotransferase gene continues. Emerman
and coworkers have reported a state of gene suppression in cells
genetically modiﬁed with a retrovirus in which one gene is
shutdown while the second gene undergoes normal transcription
due to promoter competition.46 Because the KG1 cells were
electroporated and put into media that was lacking G418 for the
apoptosis experiments, there would be no need for the activation of
the SV40 promoter allowing the CMV to transcribe the hiwi gene
unperturbed, thus allowing for the rapid induction of apoptosis
resulting in eventual cell death.
During steady-state hematopoiesis, most stem cells are quies-
cent or cycling extremely slowly.47-52 Stem cell quiescence may be
a passive process involving the absence of proliferation or an active
process that occurs as a consequence of a variety of negative
inhibitors of hematopoiesis.53-55 The observation that hiwi expres-
sion is associated with diminished proliferation of an immortalized
leukemia cell line suggests that the expression of this gene might
play a role in maintenance of stem cell quiescence or down-
regulation of stem cell or progenitor cell cycling. This is somewhat
surprising because it has been reported that piwi causes cellular
division within a Drosphila-based model.56 Further studies to
address the issue of hiwi function will be conducted in primitive
primary HSCs.
In Drosophila, piwi is expressed both in the terminal ﬁlament
cells and the germline. The piwi gene in the terminal ﬁlament
functions to affect stem cell self-replication, whereas piwi expres-
sion in the germline does not appear to be required for GSC
self-replication.7 We attempted to determine if a similar relation-
ship existed between marrow stroma cells and HSCs. Many of the
regulatory signals that control stem cell development are dependent
on cellular interactions between marrow stroma and HSCs.17,18
Although hiwi was expressed in marrow CD341 cells, it was not
expressed by marrow stroma or marrow mesenchymal stem cells,
which are capable of differentiating into not only marrow stroma
but also other components of the hematopoietic niche such as
adipocytes, osteoblasts, tenoblasts and cartilage forming cells.16
These data indicate that the potential role of hiwi in human stem
cell development is quite different from that which occurs in the
Drosophila model. It remains possible that the hiwi present in
CD341 cells may play a role as an intrinsic regulator of stem cell
self-replication. Testing of this hypothesis remains an objective of
our ongoing investigations.
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